Re: Pitchforks
|
2
|
Resverlogix Corp.
|
Dec 19, 2020 08:01AM
|
Re: Pondering the biomarkers...
|
7
|
Resverlogix Corp.
|
Nov 22, 2019 10:21AM
|
Re: Positive data on cognition already 'baked in'?
|
4
|
Resverlogix Corp.
|
Dec 03, 2019 12:07PM
|
Re: Positives vs. negatives
|
8
|
Resverlogix Corp.
|
Nov 21, 2019 10:20AM
|
Re: Possibility?
|
3
|
Resverlogix Corp.
|
May 10, 2024 08:59AM
|
Re: Possibility?
|
2
|
Resverlogix Corp.
|
May 07, 2024 02:22PM
|
Re: Possibility?
|
3
|
Resverlogix Corp.
|
May 08, 2024 10:06AM
|
Re: Potential market
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 03:49AM
|
Re: Potential market
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 02:41PM
|
Re: Potential market
|
5
|
Resverlogix Corp.
|
Nov 17, 2019 03:49PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
8
|
Resverlogix Corp.
|
Nov 20, 2022 08:29AM
|
Re: Power play
|
4
|
Resverlogix Corp.
|
Oct 09, 2019 08:52PM
|
Re: Predictions ......
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 12:59AM
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
May 13, 2021 07:13PM
|
Re: Presentation
|
7
|
Resverlogix Corp.
|
Sep 11, 2020 03:41PM
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 23, 2020 01:11PM
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 17, 2021 08:49AM
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 16, 2021 09:29PM
|
Re: Presentation is over
|
1
|
Resverlogix Corp.
|
Jun 09, 2020 12:37PM
|
Re: Presentation is over
|
4
|
Resverlogix Corp.
|
Jun 09, 2020 09:36AM
|